Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure (Beta3_LVH)

Clinical Trial ID NCT02599480

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02599480

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation 2013 0.89
2 Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv Pharmacol 2010 0.88
3 beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?". J Am Coll Cardiol 2009 0.83
Next 100